CD33 and acute myeloid leukemia: Five additional CD33 SNPs identified in AML patients, namely rs1803254 (G > C; 3’UTR), rs35112940 (G > A; Arg304Gly), rs2455069 (A > G; Arg69Gly), rs61736475 (T > C; Ser305Pro) and rs201074739 (CCGG deletion), can impact on GO response [88].